Study: Green tea compound targets cancer-linked protein

A major green tea compound called epigallocatechin gallate or EGCG may target a key cancer-linked protein HSP90, meaning that EGCG may prevent a host of cancers, according to a new study presented at an international conference on diet and cancer, researchers funded by the American Institute for Cancer Research (AICR).

EGCG, a major component found in green tea, has been extensively studied for its chemo preventive properties against a series of cancers such as breast, prostate, bladder, colon, stomach, pancreas and esophagus.